These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 8260090

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antigen processing and presentation.
    Wilson IA.
    Clin Transplant; 1995 Jun; 9(3 Pt 2):260-1. PubMed ID: 7670173
    [No Abstract] [Full Text] [Related]

  • 3. Faulty major histocompatibility complex class I function linked to autoimmune diabetes.
    Faustman D.
    Transplant Proc; 1992 Dec; 24(6):2874-6. PubMed ID: 1465979
    [No Abstract] [Full Text] [Related]

  • 4. The major histocompatibility complex in man.
    Buc M.
    Folia Biol (Praha); 1993 Dec; 39(5):223-42. PubMed ID: 8206168
    [Abstract] [Full Text] [Related]

  • 5. Antigen processing: a critical factor in rational vaccine design.
    Yewdell JW, Bennink JR.
    Semin Hematol; 1993 Oct; 30(4 Suppl 4):26-32; discussion 33-4. PubMed ID: 8303307
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Peptides made to order.
    Rammensee HG.
    Immunity; 2006 Nov; 25(5):693-5. PubMed ID: 17098199
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunology. Inside the gearbox of the dendritic cell.
    Watts C.
    Nature; 1997 Aug 21; 388(6644):724-5. PubMed ID: 9285579
    [No Abstract] [Full Text] [Related]

  • 10. Peptide-MHC complexes assembled following multiple pathways: an opportunity for the design of vaccines and therapeutic molecules.
    Corradin G, Demotz S.
    Hum Immunol; 1997 May 21; 54(2):137-47. PubMed ID: 9297532
    [Abstract] [Full Text] [Related]

  • 11. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C, Rogers WO, Gowda K, Doolan DL.
    Immunol Lett; 2007 Aug 15; 111(2):92-102. PubMed ID: 17604849
    [Abstract] [Full Text] [Related]

  • 12. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.
    Watts C.
    Nat Immunol; 2004 Jul 15; 5(7):685-92. PubMed ID: 15224094
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Molecular engineering of the major histocompatibility complex for immunomodulation.
    Ghobrial RR, Stepkowski SM, Kahan BD.
    Clin Transplant; 1995 Jun 15; 9(3 Pt 2):237-45. PubMed ID: 7670169
    [No Abstract] [Full Text] [Related]

  • 19. Presentation of antigens derived from microorganisms residing in host-cell vacuoles.
    Ojcius DM, Gachelin G, Dautry-Varsat A.
    Trends Microbiol; 1996 Feb 15; 4(2):53-9. PubMed ID: 8820567
    [Abstract] [Full Text] [Related]

  • 20. Peptide binding and antigen presentation by class II histocompatibility glycoproteins.
    Jensen PE.
    Biopolymers; 1997 Feb 15; 43(4):303-22. PubMed ID: 9316394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.